University of Virginia Comprehensive Cancer Center is a clinical research site located in Charlottesville, Virginia, United States 22903.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Virginia Comprehensive Cancer Center has participated in 28 clinical trials with 18 currently active.
Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.
Sponsors: Kura Oncology, Inc., GOG Foundation, Pfizer.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Virginia Comprehensive Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Virginia Comprehensive Cancer Center has 28 clinical trials on record, with 18 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.
Yes — University of Virginia Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.